Amy J Santamour, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4264 East Rd, Turin, NY 13473 Phone: 315-348-2500 Fax: 315-348-2510 |
Angela Groff, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5429 Carpenter Rd, Turin, NY 13473 Phone: 315-335-4345 |
News Archive
Today, Upp Technology, a leading provider of public health solutions, announced the new enhanced version of their irms|PM (Patient Management) software product.
Fraunhofer USA Center for Molecular Biotechnology, a not-for-profit, Delaware-based organization focused on developing a proprietary plant-based protein production platform and its applications in vaccine and therapeutic fields, today announced positive interim results from the first human trial of plant-produced H1N1 influenza vaccine that began on September 13, 2010.
Primco Management Inc., a medical marijuana, real estate management and multi-media company today announced that the Company has acquired a 51% interest in Pops Edibles, a San Francisco bay area based medical marijuana boutique that specializes in the formulation and manufacture of both Tetrahydrocannabinol ("THC") and Cannabidiol ("CBD") based 100% organic lollipops designed for both the medical and recreational communities.
By focusing on the identification of common genetic variants, researchers have identified 57 single nucleotide polymorphisms (SNPs) that predict-with a high degree of certainty-the risk that siblings of children with Autism Spectrum Disorder (ASD) will also develop the condition. The findings were presented at the International Meeting for Autism Research.
Sermo (http://www.sermo.com), the world's largest online physician's community, today announced a new Sermo Event(TM) Report assessing physician perception of FDA's "refuse to file" (RTF) letter on EMD Serono's Cladribine tablets and its potential impact, if any, on Novartis' oral MS agent in development; Fingolimod. Cladribine is expected to be one of the first oral agents to be approved for the treatment of relapsing and remitting multiple sclerosis.
› Verified 7 days ago